Edward A. Stadtmauer

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Co-Leader, Hematologic Malignancies Program, University of Pennsylvania Abramson Cancer Center
Co-Leader, Hematologic Malignancies Translational Center of Excellence, Penn Medicine/Abramson Cancer Center
Chief, Section of Hematologic Malignancies, Division of Hematology-Oncology, Department of Medicine
Department: Medicine

Contact information
2 Perelman Center for Advanced Medicine
34th and Civic Center Bld
Philadelphia, PA 19104
Office: 2156627910
Fax: 215-662-4064
A.B. (Biochemistry)
Cornell University, College of Arts and Sciences, 1979.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 1983.
Permanent link

Description of Research Expertise

Clinical trials, Bone Marrow Transplant

Description of Itmat Expertise

Dr. Stadtmauer is pursuing new treatment approaches to improve the long term survival of patients with leukemia, lymphoma, myeloma and those undergoing bone marrow transplant.

Selected Publications

Linette, Gerald P. Stadtmauer, Edward A. Maus, Marcela V. Rapoport, Aaron P. Levine, Bruce L. Emery, Lyndsey. Litzky, Leslie. Bagg, Adam. Carreno, Beatriz M. Cimino, Patrick J. Binder-Scholl, Gwendolyn K. Smethurst, Dominic P. Gerry, Andrew B. Pumphrey, Nick J. Bennett, Alan D. Brewer, Joanna E. Dukes, Joseph. Harper, Jane. Tayton-Martin, Helen K. Jakobsen, Bent K. Hassan, Namir J. Kalos, Michael. June, Carl H.: Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Blood 122(6): 863-71, Aug 8 2013.

Landsburg, Daniel J. Stadtmauer, Edward. Loren, Alison. Goldstein, Steven. Frey, Noelle. Nasta, Sunita D. Porter, David L. Tsai, Donald E. Perl, Alexander E. Hexner, Elizabeth O. Luger, Selina.: Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens. American Journal of Hematology 88(8): 657-60, Aug 2013.

Vose, Julie M. Carter, Shelly. Burns, Linda J. Ayala, Ernesto. Press, Oliver W. Moskowitz, Craig H. Stadtmauer, Edward A. Mineshi, Shin. Ambinder, Richard. Fenske, Timothy. Horowitz, Mary. Fisher, Richard. Tomblyn, Marcie.: Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial. Journal of Clinical Oncology 31(13): 1662-8, May 1 2013.

Cook, R J. Wang, Z. Arora, M. Lazarus, H M. Kasow, K A. Champagne, M A. Saber, W. van Besien, K M. Hale, G A. Copelan, E A. Elmongy, M. Ueno, N T. Horn, B N. Slavin, S. Bishop, M R. Stadtmauer, E A.: Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis. Bone Marrow Transplantation 47(11): 1455-8, Nov 2012.

Siegel, David S. Martin, Thomas. Wang, Michael. Vij, Ravi. Jakubowiak, Andrzej J. Lonial, Sagar. Trudel, Suzanne. Kukreti, Vishal. Bahlis, Nizar. Alsina, Melissa. Chanan-Khan, Asher. Buadi, Francis. Reu, Frederic J. Somlo, George. Zonder, Jeffrey. Song, Kevin. Stewart, A Keith. Stadtmauer, Edward. Kunkel, Lori. Wear, Sandra. Wong, Alvin F. Orlowski, Robert Z. Jagannath, Sundar.: A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma. Blood 120(14): 2817-25, Oct 4 2012.

Nademanee, Auayporn P. DiPersio, John F. Maziarz, Richard T. Stadtmauer, Edward A. Micallef, Ivana N. Stiff, Patrick J. Hsu, Frank J. Bridger, Gary. Bolwell, Brian J.: Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial. Biology of Blood & Marrow Transplantation 18(10): 1564-72, Oct 2012.

Bensinger, William. Maziarz, Richard T. Jagannath, Sundar. Spencer, Andrew. Durrant, Simon. Becker, Pamela S. Ewald, Brett. Bilic, Sanela. Rediske, John. Baeck, Johan. Stadtmauer, Edward A.: A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma. British Journal of Haematology 159(1): 58-66, Oct 2012.

Tizon, R. Frey, N. Heitjan, D F. Tan, K S. Goldstein, S C. Hexner, E O. Loren, A. Luger, S M. Reshef, R. Tsai, D. Vogl, D. Davis, J. Vozniak, M. Fuchs, B. Stadtmauer, E A. Porter, D L.: High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. Bone Marrow Transplantation 47(10): 1332-7, Oct 2012.

Ahmadi, T. McQuade, J. Porter, D. Frey, N. Loren, A W. Goldstein, S C. Svoboda, J. Stadtmauer, E. Schuster, S J. Nasta, S D.: Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance. Bone Marrow Transplantation 47(8): 1082-6, Aug 2012.

Reshef, Ran. Luger, Selina M. Hexner, Elizabeth O. Loren, Alison W. Frey, Noelle V. Nasta, Sunita D. Goldstein, Steven C. Stadtmauer, Edward A. Smith, Jacqueline. Bailey, Sarah. Mick, Rosemarie. Heitjan, Daniel F. Emerson, Stephen G. Hoxie, James A. Vonderheide, Robert H. Porter, David L.: Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. New England Journal of Medicine 367(2): 135-45, Jul 12 2012.

back to top
Last updated: 01/05/2014
The Trustees of the University of Pennsylvania